You have 2 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Multi drug resistant pathogens

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypervirulent and Multi-drug Resistant Pathogens

Recruiting
  • Multiresistant Bacterial Pathogens
  • Virulent Bacterial Pathogens
  • Analysis of Bacterial Genome
  • Basel, Switzerland
  • +4 more
Dec 15, 2021

Risk Factors for Multidrug Resistant Bacteria at ICU Admission

Not yet recruiting
  • Multi Drug Resistant Bacteria
  • Identification o Multi Drug Resistant Bacteria
  • (no location specified)
Aug 2, 2023

Ventilator Associated Pneumonia by Multi-Drug Resistant Organism

Completed
  • Ventilator Associated Pneumonia
  • Multi-antibiotic Resistance
  • Ventilation
  • Muscat, Oman
    Sultan Qaboos University Hospital
Sep 28, 2022

Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases

Not yet recruiting
  • Multi-Drug Resistant Hiv-1 Infection
  • HIV-1 Infection
  • UB-421
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Household Transmission Dynamics of Multidrug Resistant

Not yet recruiting
  • Adults Patients, With Fecal Carriage of Multi-Drug Resistant Enterobacterales (MDR-E)
    • (no location specified)
    Apr 3, 2023

    Perinatal Transmission of MDR Bacteria

    Recruiting
    • E. Coli Infection
    • Multi-antibiotic Resistance
      • Chicago, Illinois
        Prentice Women's Hospital
      Nov 20, 2023

      Lung Cancer, Organoid, NSCLC Trial in Wuxi (Antitumor therapy guided by organoid drug sensitivity test)

      Recruiting
      • Lung Cancer
      • +2 more
      • Antitumor therapy guided by organoid drug sensitivity test
      • Wuxi, Jiangsu, China
        Affiliated Hospital of Jiangnan University
      Feb 2, 2023

      Infection Control Trial in Baltimore (Enhanced cleaning of surfaces in ICU rooms, Sham enhanced cleaning of surfaces in ICU

      Completed
      Has Results
      • Infection Control
      • Enhanced cleaning of surfaces in ICU rooms
      • Sham enhanced cleaning of surfaces in ICU rooms
      • Baltimore, Maryland
        University of Maryland, Baltimore
      Feb 15, 2022

      Multi-antibiotic Resistance Trial in Vancouver (Fecal Microbiota Transplantation (FMT))

      Recruiting
      • Multi-antibiotic Resistance
      • Fecal Microbiota Transplantation (FMT)
      • Vancouver, British Columbia, Canada
      • +1 more
      Oct 4, 2021

      AMR-DetecTool for the Diagnostic of MDR Bacterial Infections

      Completed
      • Bacterial Sensitivity Tests
      • Antimicrobial Drug Resistance
      • AMR LFIA Assay
      • Le Kremlin-Bicêtre, France
      • +2 more
      Jan 12, 2023

      Urinary Tract Infection, Acute Pyelonephritis, Hospital Acquired Pneumonia Trial in China (Zavicefta, Ceftazidime-Avibactam,

      Recruiting
      • Urinary Tract Infection
      • +5 more
      • Zavicefta, Ceftazidime-Avibactam
      • Best Available Treatment
      • Bengbu, Anhui, China
      • +34 more
      Aug 3, 2022

      Pharmacometrics to Advance Novel Regimens for Drug-resistant

      Recruiting
      • Multi-drug Resistant Tuberculosis
        • Almaty, Kazakhstan
        • +6 more
        Nov 1, 2022

        Metastatic Castration-resistant Prostate Cancer Trial ([177Lu]Ludotadipep 3.7 GBq)

        Not yet recruiting
        • Metastatic Castration-resistant Prostate Cancer
        • [177Lu]Ludotadipep 3.7 GBq
        • (no location specified)
        Jul 12, 2022

        Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid

        Active, not recruiting
        • Tuberculosis
        • +4 more
        • Bedaquiline Oral Tablet
        • +7 more
        • Port Elizabeth, Eastern Cape, South Africa
        • +1 more
        Oct 20, 2022

        Multi-drug Resistant Organism Trial in Atlanta (Microbiome Therapeutic, Placebo)

        Not yet recruiting
        • Multi-drug Resistant Organism
        • Microbiome Therapeutic
        • Placebo
        • Atlanta, Georgia
        • +4 more
        Apr 18, 2023

        Pulmonary Tuberculosis Trial in Beijing (WX-081, Bedaquiline, Standard treatment)

        Recruiting
        • Pulmonary Tuberculosis
        • Beijing, Beijing, China
          Beijing Chest Hospital affiliated to Capital Medical University
        Dec 14, 2021

        Multidrug-resistant Tuberculosis

        Recruiting
        • Multi-Drug Resistant Tuberculosis
          • Paris, France
            Pitié Salpêtrière Hospital
          Mar 28, 2022

          Plasmid Inhibitors and Antimicrobial Drugs Against Clinical

          Not yet recruiting
          • Synergy Between Plasmid Inhibitors and Combined Antibiotics
            • (no location specified)
            Jun 27, 2023

            Multi-Drug Resistant Organism Trial in Decatur (Allogeneic Microbiota in Glycerol (10%) (AMG))

            Not yet recruiting
            • Multi-Drug Resistant Organism
            • Allogeneic Microbiota in Glycerol (10%) (AMG)
            • Decatur, Georgia
              Emory Long-Term Acute Care
            Mar 20, 2023

            Pneumonia Trial in Beijing (M-ROSE analysis)

            Recruiting
            • Pneumonia
            • M-ROSE analysis
            • Beijing, Beijing, China
              Yi Tao
            Apr 19, 2022

            Multi Drug Resistant Tuberculosis, HIV Trial in Durban (Adherence support intevention)

            Not yet recruiting
            • Multi Drug Resistant Tuberculosis
            • HIV Infections
            • Adherence support intevention
            • Durban, KwaZulu-Natal, South Africa
              King DinuZulu Hospital
            Nov 21, 2022

            Urinary Tract Infections Trial in United States (LBP-EC01, Placebo, TMP/SMX)

            Recruiting
            • Urinary Tract Infections
            • Anniston, Alabama
            • +6 more
            Aug 4, 2022

            Prostate Cancer Trial in Washington, Chicago, Baltimore (Enzalutamide, LY2157299)

            Recruiting
            • Prostate Cancer
            • Washington, District of Columbia
            • +3 more
            Jun 1, 2022

            Multi-Drug Resistant Organisms, Late-Onset Sepsis, Neonatal, Antimicrobial Resistance Trial in Edmonton (Exposure of interest)

            Recruiting
            • Multi-Drug Resistant Organisms
            • +2 more
            • Exposure of interest
            • Edmonton, Alberta, Canada
              Royal Alexandra Hospital
            Dec 7, 2021

            Chronic Kidney Disease, Glomerular Filtration Rate, Drug Resistance Trial in Konya

            Completed
            • Chronic Kidney Disease
            • +2 more
              • Konya, Turkey
                Konya Numune Hospital
              Apr 3, 2021